Choksi Asia Peer Comparison

BSE: 530427

₹244.95

₹-3.70 (-1.49%)

As on 27-Aug-2026 12:40IST

Market cap

₹142 Cr

Revenue (TTM)

₹47 Cr

P/E Ratio

27.3

P/B Ratio

3.8

Div. Yield

0 %

Edit

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Market cap (₹ Cr)	142	39,487	32,185	32,293	15,158
Revenue (₹ Cr)	47	4,683	4,213	2,891	857
Net Profit (₹ Cr)	5.19	552.34	190.80	546.30	187.49
Net Margin (%)	10.80	11.55	4.49	18.23	21.32
RoE (%)	12.76	14.93	9.45	23.03	20.58
Price to Earnings	27.33	71.00	157.54	59.59	80.85
Price-To-Book	3.76	9.60	8.51	12.36	15.00

Income Statement (₹ Cr)

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Operating Revenue	46.63	4,683.37	4,212.50	2,890.80	857.13
Total Income	48.03	4,783.78	4,248.00	2,995.90	879.41
Total Expenditure	39.85	3,704.62	3,379.70	2,053.10	495.19
EBITDA	6.78	978.75	832.80	837.70	361.94
Depreciation	0.30	246.41	330.60	171.60	96.06
EBIT	6.49	732.34	502.20	666.10	265.89
Interest	0.36	92.01	253.30	24.40	36.75
Other Income	1.40	100.41	35.50	105.10	22.28
Exceptional Items	0.00	-20.61	-11.20	-30.10	0.00
Profit before Tax	7.53	720.14	273.20	716.70	251.42
Provision for Tax	2.34	167.80	82.40	170.40	63.93
Profit after Tax	5.19	552.34	190.80	546.30	187.49

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Shareholder's Funds	42.11	3,961.57	2,247.40	2,508.20	957.15
Minority Interest	0.00	3.84	9.90	-4.40	0.00
Non-Current Liabilities	0.97	1,293.60	3,961.30	154.00	426.03
Current Liabilities	4.35	627.13	1,238.90	450.70	123.87
Total Liabilities	47.18	4,766.23	5,689.20	2,713.41	1,273.62

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Non-Current Assets	17.42	3,128.95	5,416.90	1,176.30	737.24
Current Assets	29.02	1,674.92	937.40	1,566.60	321.90
Total Assets	47.18	4,766.23	5,689.20	2,713.41	1,273.62
Total Debt*	4.77	327.88	1,910.90	0.00	0.00
Net Current Assets	24.67	1,047.79	-301.50	1,115.90	198.03
Contingent Liabilities	17.15	88.77	83.80	10.59	0.13

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Cash From Operating Activities	-2.87	623.76	581.80	568.89	224.47
Cash Flow from Investing Activities	0.63	-720.94	-1,116.20	-303.16	-181.88
Cash from Financing Activities	-1.20	-97.23	543.10	-334.03	-52.05
Net Cash Inflow / Outflow	-3.43	-194.41	8.70	-68.31	-9.45

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
ROCE (%)	18.35	20.50	19.02	31.53	30.27
ROE (%)	12.76	14.93	9.45	23.03	20.58
ROA (%)	10.96	10.35	2.83	18.64	13.49
EBIT Margin (%)	13.91	15.64	11.92	23.04	31.02
Net Margin (%)	10.80	11.55	4.49	18.23	21.32
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Revenue Growth (%)	13.36	21.27	30.90	14.29	20.18
EBIT Growth (%)	107.62	0.94	-16.88	15.64	26.22
Net Profit Growth (%)	96.22	3.43	-52.81	5.38	24.27
EPS Growth (%)	34.23	2.70	-42.60	-30.51	23.44
Book Value Growth (%)	109.12	16.71	16.93	17.68	20.98

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Price / Earnings	27.33	68.59	143.10	45.43	80.57
Price / Book Value	3.76	9.55	8.39	12.44	14.98
Dividend Yield (%)	0.00	0.03	0.00	1.06	0.14
EV/EBITDA	20.13	39.62	41.92	37.22	41.05
Market Cap (₹ Cr)	38.79	32,181.74	25,571.93	20,714.85	10,333.01

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debt to Equity	0.01	0.15	1.19	0.00	0.00
Short term debt to equity ratio	0.05	--	0.06	--	--
Current Ratio	6.67	2.67	0.76	3.48	2.60
Quick Ratio	4.56	2.54	0.68	3.38	2.56
Interest Coverage	21.84	8.83	2.08	30.37	7.84

	Choksi Asia	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debtors to sales (%)	20.28	8.78	13.16	3.83	2.43
Asset Turnover	0.99	0.88	0.62	0.99	0.62
Receivable days	42.00	25.07	41.48	12.27	8.30
Inventory Days	50.94	6.62	6.82	5.45	2.71
Payable days	39.49	79.17	135.60	134.04	142.28
Cash Conversion Cycle	53.45	-47.48	-87.31	-116.32	-131.27

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.